AGC to Expand GMP-Compliant Synthetic Pharmaceutical Intermediate and Active Ingredient Production Capacity Tenfold
— Broadened CDMO Business Will Cover Commercial New Drugs As Well As in Development Stage of Ones – TOKYO, July 12, 2018 /PRNewswire/ — AGC Inc., a world-leading manufacturer of…